OpenAI and Molecule.one show how a near-autonomous AI chemist using GPT-5.4 improved a key drug-making reaction, advancing medicinal chemistry research.
New models reset the capability and price-performance frontier. Teams re-evaluate what to build on whenever a launch shifts what's possible per dollar.
Companies and models mentioned in this story — open their pages and live prices
Summaries are aggregated for information only — follow the source link for the full story. Demo entries are illustrative.